Results 1 to 10 of about 546,199 (245)

In-Vitro Biocompatibility and Hemocompatibility Study of New PET Copolyesters Intended for Heart Assist Devices. [PDF]

Polymers (Basel), 2020
(1) Background: The evaluation of ventricular assist devices requires the usage of biocompatible and chemically stable materials. The commonly used polyurethanes are characterized by versatile properties making them well suited for heart prostheses ...
Gawlikowski M, El Fray M, Janiczak K, Zawidlak-Węgrzyńska B, Kustosz R.   +4 more
europepmc   +2 more sources

Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure

Journal of the American Medical Association (JAMA), 2023
IMPORTANCE Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity.
Mandeep R. Mehra, Ivan Netuka, Nir Uriel, Jason N. Katz, Francis D. Pagani, Ulrich P. Jorde, Finn Gustafsson, Jean M. Connors, Peter Ivák, Jennifer Cowger, John Ransom, Aditya Bansal, Koji Takeda, Richa Agarwal, Mirnela Byku, Michael M. Givertz, Abbas Bitar, Shelley Hall, Daniel Zimpfer, J. David Vega, Manreet Kanwar, Omar Saeed, Daniel J. Goldstein, Rebecca Cogswell, Farooq H. Sheikh, Matthew Danter, Yuriy Pya, Anita Phancao, John Henderson, D. Crandall, Kartik S. Sundareswaran, Edward G. Soltesz, Jerry D. Estep, Scott Silvestry, Antone Tatooles, Nasir Siulemanjee, Brett C. Sheridan, Sanjeev Gulati, Eugene S. Chung, Clément Delmas, Carmelo A. Milano, Pierre Dos Santos, Pavan Atluri, Douglas Horstmanshof, David A. D’Alessandro, Sriram Nathan, Peter Eckman, Anelechi Anyanwu, Anna Mara Scandroglio, Alessandro Ortalda, Ezequiel Molina, Jacob Abraham, Hoong Sern Lim, Robert Adamson, Ashwin Ravichandran, Chris Hayward, William Hiesinger, John W. Entwistle, Jennifer Conway, Eric Adler, Jonathan Grinstein, Andreas Brieke, Mary Keebler, Jeffrey D. Alexis, Igor Gošev, Craig H. Selzman, David M. Kaye, David M Kaye   +67 more
openalex   +3 more sources

Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience

Heliyon, 2023
Background: Malignancy is a significant, life-limiting complication after lung transplantation (LuTx) and the second common long-term cause of death. We aimed to investigate its incidence and effect on the outcome.
Konstantina Spetsotaki, Achim Koch, Christian Taube, Dirk Theegarten, Markus Kamler, Nikolaus Pizanis   +5 more
doaj   +1 more source

Trends in contemporary advanced heart failure management: an in-depth review over 30 years of heart transplant service in Hong Kong

Korean Journal of Transplantation, 2022
Background : The year 2022 marks the 30th anniversary of heart transplant service in Hong Kong (HK). In this study, we describe prevailing trends and outcomes of advanced heart failure (AHF), including heart transplantations (HTx), in HK over the past 30
Yue Yan Katherine Fan, Ka Lam Wong, Ka Lai Cally Ho, Tai Leung Daniel Chan, Oswald Joseph Lee, Chi Yui Yung, Kin Shing Lun, Mo Chee Elaine Chau, Shui Wah Clement Chiu, Lik Cheung Cheng, Wing Kuk Timmy Au   +10 more
doaj   +1 more source

Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation

ESC Heart Failure, 2021
Heart transplantation (HTx) represents optimal care for advanced heart failure. Left ventricular assist devices (LVADs) are often needed as a bridge‐to‐transplant (BTT) therapy to support patients during the wait for a donor organ.
M. Immohr, U. Boeken, F. Mueller, E. Prashovikj, M. Morshuis, C. Böttger, H. Aubin, J. Gummert, P. Akhyari, A. Lichtenberg, R. Schramm   +10 more
semanticscholar   +1 more source

Mechanical Circulatory Assist Devices: Time for More Attention by Iranian Cardiologists

Journal of Tehran University Heart Center, 2022
-
Haleh Ashraf, Sepideh Taghavi, Hossein Navid   +2 more
doaj   +1 more source

Resultados del uso de dispositivos de asistencia ventricular de corta-media duración como puente al trasplante cardiaco

Cirugía Cardiovascular, 2022
Resumen: Introducción y objetivo: Evaluar el resultado del uso de dispositivos de asistencia ventricular de corta-media duración, tipo Centrimag e Impella, en pacientes en INTERMACS 1-3, como puente al trasplante cardiaco. Material y método: Del 2015 al
Carlos Domínguez-Massa, Manuel Pérez-Guillen, Javier Sirgo-González, Paulina M. Briz-Echeverría, José A. Rincón-Almanza, Claudia M. Aguirre-Ramón, Tomás Heredia-Cambra, María J. Dalmau-Sorlí, Salvador Torregrosa-Puerta, Iván Martín-González, Eduardo Tébar-Botí, Francisco J. Valera-Martínez, Juan B. Martínez-León   +12 more
doaj   +1 more source

Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial.

Journal of the American Medical Association (JAMA), 2022
Importance Although durable left ventricular assist device (LVAD) therapy has emerged as an important treatment option for patients with advanced heart failure refractory to pharmacological support, outcomes, including survival, beyond 2 years remain ...
M. Mehra, D. Goldstein, J. Cleveland, J. Cowger, Shelley Hall, C. Salerno, Y. Naka, D. Horstmanshof, J. Chuang, Aijia Wang, N. Uriel   +10 more
semanticscholar   +1 more source

An Up-to-Date Literature Review on Ventricular Assist Devices Experience in Pediatric Hearts

Life, 2022
Ventricular assist devices (VAD) have gained popularity in the pediatric population during recent years, as more and more children require a heart transplant due to improved palliation methods, allowing congenital heart defect patients and children with ...
Ștefana Maria Moisă, Alexandru Burlacu, Crischentian Brinza, Eliza Cinteză, Lăcrămioara Ionela Butnariu, Elena Țarcă, Alexandru Florinel Oancea, Ioana-Alecsandra Munteanu, Valentin Munteanu, Laura Stătescu, Laura Mihaela Trandafir   +10 more
doaj   +1 more source

Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]

, 2020
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric, Elkind, Jae, Morris, Gerald P, Ostberg-Braun, Oscar, Silva Enciso, Jorge, Sobczyk, Juliana   +5 more
core   +1 more source